Developer docs
API playgroundTry for free, no card

Search company profiles

Xstrahl

Full company profile

uuid0009edl

Namestring
Xstrahl
Legal namestring
Xstrahl Ltd
Websiteurl
xstrahl.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Xstrahl is a privately-held medical device company founded in 1999 and headquartered in Surrey, United Kingdom, with operating entities in the United States (Suwanee, Georgia) and Germany. The company designs and manufactures superficial and orthovoltage X-ray therapy systems used to treat non-melanoma skin cancers, keloid scarring, and other benign conditions, alongside image-guided preclinical radiation research platforms used by academic and pharmaceutical researchers. Its clinical portfolio includes the Radiant Aura dual-modality system (combining electronic brachytherapy and orthovoltage in one platform), and the Xstrahl 100/150/200/300 series covering a 50–300 kV energy range. Its research portfolio includes the SARRP image-guided small animal irradiator, SARRP FLASH and CIX FLASH ultra-high dose rate systems, the SARRP Beamline, XenX, and the CIX family of cabinet irradiators, supported by FDA 510(k)-cleared XBeam treatment planning software and Monte Carlo simulation tools (SmART-RAD, MuriSuite, Voxl).

Xstrahl monetizes primarily through direct enterprise sales of high-value capital equipment to hospitals, dermatology clinics, and research institutions, with quote-based pricing ranging from hundreds of thousands to millions of dollars per system. Recurring revenue comes from multi-year technical support, maintenance, post-market surveillance, and the company's 20-year technical training program delivered at its Birmingham, UK facility. The go-to-market blends direct enterprise field sales, inside sales for mid-market accounts, regional distributors (e.g., Nozomi Medical in Uzbekistan), and active participation at clinical and research conferences including AAD, ESTRO, ACRO, and RRS.

The company serves three primary customer segments: dermatologists and dermatology practices (treating NMSC and keloids in office-based settings), radiation oncologists and hospital oncology departments (delivering orthovoltage radiotherapy for skin and head/neck cancers), and life science researchers (using SARRP and CIX systems for translational radiation research including FLASH studies). Notable customers include Duke University, Cancer Research UK Manchester Institute, CRUK RadNet Centre Glasgow, Queens University Belfast, Norfolk & Norwich University Hospitals, Fondazione IRCCS Ca' Granda, and Valley View Hospital. Xstrahl operates as a management-owned private company with no disclosed institutional investors and no M&A activity in the available record.

Short descriptiontext

Xstrahl is a privately-held medical device company that designs and manufactures superficial and orthovoltage X-ray therapy systems for treating non-melanoma skin cancers and keloids, plus image-guided preclinical radiation research platforms for academic and pharmaceutical researchers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDuluth, United States
HQ citystring
Duluth
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiation therapy equipment, orthovoltage X-ray systems, superficial radiotherapy devices, preclinical radiation research, electronic brachytherapy systems
Industry3 codes
PRIMARYHLAHABAA
X-ray & Fluoroscopy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAKAFAC
Radiation Oncology
SECONDARYHLAHABAH
Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code2 codes
  • Irradiation Apparatus Manufacturing334517
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Commercial Physical & Biological Research8731
Product category
Radiation Therapy Equipment
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Systems Hardware Sales
TypeHardware Sales
Description

Sale of capital equipment including clinical radiation therapy systems (Radiant Aura, Xstrahl 100/150/200/300 series) and research systems (SARRP, cabinet irradiators). These are high-value capital purchases with long sales cycles.

xstrahl.com
2Professional Services and Training
TypeProfessional Services
Description

Technical training courses on X-ray treatment systems, including installation, maintenance, and software operation. Xstrahl has been delivering technical training for over 20 years.

xstrahl.com
3Technical Support and Maintenance
TypeProfessional Services
Description

Ongoing technical support services including breakdown support, application/software support, service visits, and post-market surveillance for installed systems.

xstrahl.com
4Software Licenses
TypeLicensing Royalties
Description

Treatment planning software (XBeam V2) and control software (MuriSuite, Voxl) for research systems, sold as licenses or integrated with hardware.

xstrahl.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Pricing details1 tier
1Capital Equipment - Custom Quotation
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

No publicly listed pricing. Each system configuration is quoted individually based on customer requirements, energy levels, applicators, software modules, and service packages.

xstrahl.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1RADiant
Description

Combined electronic brachytherapy and orthovoltage radiotherapy system using low energy photons for skin cancer and keloid treatment

xstrahl.com
+6 more records
Core offering1 text field

Xstrahl designs, manufactures, and sells X-ray radiation therapy and research systems. Its clinical product lines deliver superficial and orthovoltage radiotherapy plus electronic brachytherapy for treating non-melanoma skin cancer, keloid scarring, and benign conditions in dermatology and radiation oncology settings. Its research product lines deliver image-guided small animal irradiators and cabinet irradiators with FLASH ultra-high dose rate capability for translational preclinical radiation research at universities, pharmaceutical companies, and contract research organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 100% up time reported by Valley View Hospital after 3+ years of Xstrahl 150 use
+3 more records
Product overview1 text field

Xstrahl offers two primary product lines: Clinical Systems for radiation therapy and Research Systems for preclinical radiation research. The clinical portfolio includes Radiant Aura (dual modality eBT/orthovoltage), RADiant, and the Xstrahl 100/150/200/300 series for superficial and orthovoltage radiotherapy treating non-melanoma skin cancers, keloids, and benign conditions. The research portfolio includes SARRP, SARRP FLASH, SARRP Beamline, and XenX image-guided irradiators, plus CIX cabinet irradiators (CIX2, CIX3, CIXD, CIX FLASH) for preclinical studies. Supporting software includes XBeam (FDA-cleared treatment planning), MuriSuite (SARRP control), Voxl (reconstruction engine), and SmART-RAD (Monte Carlo dosimetry tool).

Product and service18 records
1Radiant Aura
CategoryClinical System — Radiotherapy
Description

Low-dose X-ray based dual modality radiation therapy system combining electronic brachytherapy (eBT) and orthovoltage radiotherapy in a single platform for treating non-melanoma skin cancers (NMSC) and keloid scarring. FDA 510(k) cleared. Targeted at hospital radiation oncology departments and office-based dermatology practices.

2Xstrahl 100
CategoryClinical System — Radiotherapy
Description

Superficial radiation therapy system for office-based treatment of superficial skin cancers, particularly non-melanoma skin cancers, in dermatology clinics.

3Xstrahl 150
CategoryClinical System — Radiotherapy
Description

Superficial radiotherapy system with higher energy levels than competing units, featuring a water-cooling system and an interlock option on the filter selection, for treating skin cancers and keloids in hospital and dermatology settings.

4Xstrahl 200
CategoryClinical System — Radiotherapy
Description

Orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions, including non-melanoma skin cancer, in hospitals and oncology centers.

5Xstrahl 300
CategoryClinical System — Radiotherapy
Description

Higher energy radiotherapy system used for definitive radiotherapy treatments of skin cancers and advanced clinical applications, including dermatology photoradiotherapy.

6SARRP (Small Animal Radiation Research Platform)
CategoryResearch System — Preclinical Irradiation
Description

Image-guided Small Animal Radiation Research Platform featuring microCT imaging, conformal irradiation, and Monte Carlo-based treatment planning for preclinical translational radiation research. Over 100 units installed globally including at Duke University.

7SARRP FLASH
CategoryResearch System — Preclinical Irradiation
Description

FLASH radiotherapy research system delivering ultra-high dose rate radiation (exceeding 40 Gy/s) on the SARRP platform, used to study FLASH-effect normal tissue sparing while maintaining tumor-killing efficacy in small animal models.

8SARRP Beamline
CategoryResearch System — Preclinical Irradiation
Description

Research irradiator using beamline technology for advanced preclinical radiation studies, including proton irradiation research.

9XenX
CategoryResearch System — Preclinical Irradiation
Description

Image-guided irradiator system for preclinical radiation research applications.

10CIX3 Cabinet Irradiator
CategoryResearch System — Cabinet Irradiator
Description

Third-generation cabinet irradiator with reduced footprint, safer controls, and larger irradiation chamber, widely used in cancer research centers globally for preclinical studies including clonogenic assays and cell irradiation.

11CIX FLASH
CategoryResearch System — Cabinet Irradiator
Description

FLASH-capability cabinet irradiator for preclinical radiobiology research enabling ultra-high dose rate studies.

12CIX2
CategoryResearch System — Cabinet Irradiator
Description

Cabinet irradiator for preclinical research enabling clonogenic assays and cell irradiation studies.

13CIXD
CategoryResearch System — Cabinet Irradiator
Description

Cabinet irradiator for preclinical research applications.

14XBeam Treatment Planning Software
CategorySoftware — Treatment Planning
Description

FDA 510(k)-cleared dose planning software that automates superficial and orthovoltage radiotherapy treatment planning, eliminates risk, and integrates with the Concerto system across Xstrahl medical devices.

15MuriSuite
CategorySoftware — Control System
Description

Next-generation control software for SARRP devices providing intuitive control and management of preclinical radiation research workflows.

16Voxl
CategorySoftware — Reconstruction Engine
Description

Reconstruction engine for the SARRP enabling advanced image reconstruction for preclinical studies.

17SmART-RAD
CategorySoftware — Dosimetry Add-on
Description

Monte Carlo simulation tool for X-ray cabinet radiobiology irradiators that simulates X-ray fields for dosimetric validation and treatment planning in preclinical radiobiology research.

18Xstrahl Technical Training and Support Services
CategoryServices — Training and Support
Description

Technical training courses covering installation, maintenance, and software operation of X-ray treatment systems, together with ongoing technical support including breakdown support, application and software support, service visits, and post-market surveillance for installed Xstrahl systems. Xstrahl has delivered these technical training courses for over 20 years.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierSignificantTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-01-01
Description

Nozomi Medical serves as a distribution and installation partner for Xstrahl products in Uzbekistan. Nozomi Medical has installed 12 Xstrahl 200 units for superficial and orthovoltage radiotherapy across Uzbekistan, including at the Republican Oncology Center.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Elekta is a global leader in radiation therapy and radiosurgery (Elekta Versa HD, Gamma Knife, brachytherapy afterloaders) and directly competes with Xstrahl in hospital radiation oncology departments, though with a far broader linear accelerator portfolio.

TypeBroad incumbent
Description

Varian is the dominant external-beam radiotherapy (TrueBeam, Edge) and treatment planning (Eclipse) vendor globally and the principal incumbent competing with Xstrahl's clinical orthovoltage and research SARRP-related workflows.

TypeDirect peer
Description

IntraOp manufactures the Mobetron, a portable electron-beam intraoperative radiotherapy system; comparable orthovoltage-range radiotherapy capital equipment vendor targeting specialty oncology indications.

TypeDirect peer
Description

BEBIG Medical provides HDR/PDR brachytherapy afterloaders and seeds; competes with Xstrahl's Radiant Aura electronic brachytherapy modality in dermatology and oncology radiation treatment delivery.

TypeDirect peer
Description

Mevion manufactures compact proton therapy systems (MEVION S250) directly competing in the specialty radiotherapy capital equipment category where Xstrahl positions its clinical orthovoltage and image-guided platforms.

TypeBroad incumbent
Description

Accuray's CyberKnife and TomoTherapy systems are image-guided radiotherapy platforms competing for the same hospital capital budgets as Xstrahl's orthovoltage clinical systems in radiation oncology departments.

TypeEmerging player
Description

RaySearch develops RayStation and RayCare treatment planning and oncology information systems that overlap with Xstrahl's XBeam and MuriSuite planning/control software offerings for radiation therapy and research workflows.

TypeDirect peer
Description

Sensus Healthcare manufactures the SRT-100 superficial radiation therapy system, the most direct head-to-head competitor to Xstrahl's 100/150/200 series for non-melanoma skin cancer treatment in dermatology practices.

TypeBroad incumbent
Description

Eckert & Ziegler supplies radiation therapy products, brachytherapy seeds (IsoCord, IsoSeed), and radiotherapy-related consumables serving overlapping hospital-based cancer treatment customers.

TypeBroad incumbent
Description

Revvity (formerly PerkinElmer) supplies preclinical imaging and radiation research instrumentation; overlaps with Xstrahl's SARRP image-guided irradiator and cabinet irradiator preclinical research customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Xstrahl

Radiation Therapy Equipmentxstrahl.com

Xstrahl is a privately-held medical device company that designs and manufactures superficial and orthovoltage X-ray therapy systems for treating non-melanoma skin cancers and keloids, plus image-guided preclinical radiation research platforms for academic and pharmaceutical researchers globally.

What Xstrahl does

Xstrahl is a privately-held medical device company founded in 1999 and headquartered in Surrey, United Kingdom, with operating entities in the United States (Suwanee, Georgia) and Germany. The company designs and manufactures superficial and orthovoltage X-ray therapy systems used to treat non-melanoma skin cancers, keloid scarring, and other benign conditions, alongside image-guided preclinical radiation research platforms used by academic and pharmaceutical researchers. Its clinical portfolio includes the Radiant Aura dual-modality system (combining electronic brachytherapy and orthovoltage in one platform), and the Xstrahl 100/150/200/300 series covering a 50–300 kV energy range. Its research portfolio includes the SARRP image-guided small animal irradiator, SARRP FLASH and CIX FLASH ultra-high dose rate systems, the SARRP Beamline, XenX, and the CIX family of cabinet irradiators, supported by FDA 510(k)-cleared XBeam treatment planning software and Monte Carlo simulation tools (SmART-RAD, MuriSuite, Voxl).

Xstrahl monetizes primarily through direct enterprise sales of high-value capital equipment to hospitals, dermatology clinics, and research institutions, with quote-based pricing ranging from hundreds of thousands to millions of dollars per system. Recurring revenue comes from multi-year technical support, maintenance, post-market surveillance, and the company's 20-year technical training program delivered at its Birmingham, UK facility. The go-to-market blends direct enterprise field sales, inside sales for mid-market accounts, regional distributors (e.g., Nozomi Medical in Uzbekistan), and active participation at clinical and research conferences including AAD, ESTRO, ACRO, and RRS.

The company serves three primary customer segments: dermatologists and dermatology practices (treating NMSC and keloids in office-based settings), radiation oncologists and hospital oncology departments (delivering orthovoltage radiotherapy for skin and head/neck cancers), and life science researchers (using SARRP and CIX systems for translational radiation research including FLASH studies). Notable customers include Duke University, Cancer Research UK Manchester Institute, CRUK RadNet Centre Glasgow, Queens University Belfast, Norfolk & Norwich University Hospitals, Fondazione IRCCS Ca' Granda, and Valley View Hospital. Xstrahl operates as a management-owned private company with no disclosed institutional investors and no M&A activity in the available record.

Xstrahl firmographics

Firmographics
Name
Xstrahl
Legal name
Xstrahl Ltd
Website
https://xstrahl.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
51–100 employees
Short description
Xstrahl is a privately-held medical device company that designs and manufactures superficial and orthovoltage X-ray therapy systems for treating non-melanoma skin cancers and keloids, plus image-guided preclinical radiation research platforms for academic and pharmaceutical researchers globally.
Ownership category
akta.pro rank

Xstrahl industry classification

Industry
Product category
Radiation Therapy Equipment
NAICS
Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Surgical & Medical Instruments & Apparatus (3841), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAHABAA
X-ray & Fluoroscopy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAKAFAC
Radiation Oncology
SECONDARYHLAHABAH
Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Radiation therapy equipment
  • Orthovoltage X-ray systems
  • Superficial radiotherapy devices
  • Preclinical radiation research
  • Electronic brachytherapy systems

Where Xstrahl is headquartered

Location

Headquarters

HQ city
Duluth
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Xstrahl business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Medical Systems Hardware Sales: Sale of capital equipment including clinical radiation therapy systems (Radiant Aura, Xstrahl 100/150/200/300 series) and research systems (SARRP, cabinet irradiators). These are high-value capital purchases with long sales cycles.
  2. Professional Services and Training: Technical training courses on X-ray treatment systems, including installation, maintenance, and software operation. Xstrahl has been delivering technical training for over 20 years.
  3. Technical Support and Maintenance: Ongoing technical support services including breakdown support, application/software support, service visits, and post-market surveillance for installed systems.
  4. Software Licenses: Treatment planning software (XBeam V2) and control software (MuriSuite, Voxl) for research systems, sold as licenses or integrated with hardware.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractCapital Equipment - Custom Quotation

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Xstrahl product offering

Product offering

Core offering

Xstrahl designs, manufactures, and sells X-ray radiation therapy and research systems. Its clinical product lines deliver superficial and orthovoltage radiotherapy plus electronic brachytherapy for treating non-melanoma skin cancer, keloid scarring, and benign conditions in dermatology and radiation oncology settings. Its research product lines deliver image-guided small animal irradiators and cabinet irradiators with FLASH ultra-high dose rate capability for translational preclinical radiation research at universities, pharmaceutical companies, and contract research organizations.

Product overview

Xstrahl offers two primary product lines: Clinical Systems for radiation therapy and Research Systems for preclinical radiation research. The clinical portfolio includes Radiant Aura (dual modality eBT/orthovoltage), RADiant, and the Xstrahl 100/150/200/300 series for superficial and orthovoltage radiotherapy treating non-melanoma skin cancers, keloids, and benign conditions. The research portfolio includes SARRP, SARRP FLASH, SARRP Beamline, and XenX image-guided irradiators, plus CIX cabinet irradiators (CIX2, CIX3, CIXD, CIX FLASH) for preclinical studies. Supporting software includes XBeam (FDA-cleared treatment planning), MuriSuite (SARRP control), Voxl (reconstruction engine), and SmART-RAD (Monte Carlo dosimetry tool).

Differentiator

Problem solved

Functional benefit

Brands

  • RADiant: Combined electronic brachytherapy and orthovoltage radiotherapy system using low energy photons for skin cancer and keloid treatment
  • SARRP
  • XBeam
  • MuriSuite
  • Voxl
  • SmART-RAD
  • SmART-XPS

Products and services

  • Radiant Aura Low-dose X-ray based dual modality radiation therapy system combining electronic brachytherapy (eBT) and orthovoltage radiotherapy in a single platform for treating non-melanoma skin cancers (NMSC) and keloid scarring. FDA 510(k) cleared. Targeted at hospital radiation oncology departments and office-based dermatology practices.
  • Xstrahl 100 Superficial radiation therapy system for office-based treatment of superficial skin cancers, particularly non-melanoma skin cancers, in dermatology clinics.
  • Xstrahl 150 Superficial radiotherapy system with higher energy levels than competing units, featuring a water-cooling system and an interlock option on the filter selection, for treating skin cancers and keloids in hospital and dermatology settings.
  • Xstrahl 200 Orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions, including non-melanoma skin cancer, in hospitals and oncology centers.
  • Xstrahl 300 Higher energy radiotherapy system used for definitive radiotherapy treatments of skin cancers and advanced clinical applications, including dermatology photoradiotherapy.
  • SARRP (Small Animal Radiation Research Platform) Image-guided Small Animal Radiation Research Platform featuring microCT imaging, conformal irradiation, and Monte Carlo-based treatment planning for preclinical translational radiation research. Over 100 units installed globally including at Duke University.
  • SARRP FLASH FLASH radiotherapy research system delivering ultra-high dose rate radiation (exceeding 40 Gy/s) on the SARRP platform, used to study FLASH-effect normal tissue sparing while maintaining tumor-killing efficacy in small animal models.
  • SARRP Beamline Research irradiator using beamline technology for advanced preclinical radiation studies, including proton irradiation research.
  • XenX Image-guided irradiator system for preclinical radiation research applications.
  • CIX3 Cabinet Irradiator Third-generation cabinet irradiator with reduced footprint, safer controls, and larger irradiation chamber, widely used in cancer research centers globally for preclinical studies including clonogenic assays and cell irradiation.
  • CIX FLASH FLASH-capability cabinet irradiator for preclinical radiobiology research enabling ultra-high dose rate studies.
  • CIX2 Cabinet irradiator for preclinical research enabling clonogenic assays and cell irradiation studies.
  • CIXD Cabinet irradiator for preclinical research applications.
  • XBeam Treatment Planning Software FDA 510(k)-cleared dose planning software that automates superficial and orthovoltage radiotherapy treatment planning, eliminates risk, and integrates with the Concerto system across Xstrahl medical devices.
  • MuriSuite Next-generation control software for SARRP devices providing intuitive control and management of preclinical radiation research workflows.
  • Voxl Reconstruction engine for the SARRP enabling advanced image reconstruction for preclinical studies.
  • SmART-RAD Monte Carlo simulation tool for X-ray cabinet radiobiology irradiators that simulates X-ray fields for dosimetric validation and treatment planning in preclinical radiobiology research.
  • Xstrahl Technical Training and Support Services Technical training courses covering installation, maintenance, and software operation of X-ray treatment systems, together with ongoing technical support including breakdown support, application and software support, service visits, and post-market surveillance for installed Xstrahl systems. Xstrahl has delivered these technical training courses for over 20 years.

Quantifiable outcome

  • 100% up time reported by Valley View Hospital after 3+ years of Xstrahl 150 use
  • +3 more outcomes

Companies that use Xstrahl

Customer profile

Named customers10 records

Segments5 records

Ideal customer profiles3 records

Xstrahl technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Xstrahl partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Nozomi MedicalsignificantChannel Partner/ Reseller/ Distributor · 1 January 2024Nozomi Medical serves as a distribution and installation partner for Xstrahl products in Uzbekistan. Nozomi Medical has installed 12 Xstrahl 200 units for superficial and orthovoltage radiotherapy across Uzbekistan, including at the Republican Oncology Center.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Xstrahl competitors and assessment

Company assessment

Broad incumbents

  • Elekta: Elekta is a global leader in radiation therapy and radiosurgery (Elekta Versa HD, Gamma Knife, brachytherapy afterloaders) and directly competes with Xstrahl in hospital radiation oncology departments, though with a far broader linear accelerator portfolio.
  • Varian Medical Systems (Siemens Healthineers): Varian is the dominant external-beam radiotherapy (TrueBeam, Edge) and treatment planning (Eclipse) vendor globally and the principal incumbent competing with Xstrahl's clinical orthovoltage and research SARRP-related workflows.
  • Accuray: Accuray's CyberKnife and TomoTherapy systems are image-guided radiotherapy platforms competing for the same hospital capital budgets as Xstrahl's orthovoltage clinical systems in radiation oncology departments.
  • Eckert & Ziegler: Eckert & Ziegler supplies radiation therapy products, brachytherapy seeds (IsoCord, IsoSeed), and radiotherapy-related consumables serving overlapping hospital-based cancer treatment customers.
  • Revvity (PerkinElmer Life Sciences): Revvity (formerly PerkinElmer) supplies preclinical imaging and radiation research instrumentation; overlaps with Xstrahl's SARRP image-guided irradiator and cabinet irradiator preclinical research customer base.

Direct peers

  • IntraOp Medical: IntraOp manufactures the Mobetron, a portable electron-beam intraoperative radiotherapy system; comparable orthovoltage-range radiotherapy capital equipment vendor targeting specialty oncology indications.
  • BEBIG Medical (Mick Radio-Nuclear Instruments): BEBIG Medical provides HDR/PDR brachytherapy afterloaders and seeds; competes with Xstrahl's Radiant Aura electronic brachytherapy modality in dermatology and oncology radiation treatment delivery.
  • Mevion Medical Systems: Mevion manufactures compact proton therapy systems (MEVION S250) directly competing in the specialty radiotherapy capital equipment category where Xstrahl positions its clinical orthovoltage and image-guided platforms.
  • Sensus Healthcare: Sensus Healthcare manufactures the SRT-100 superficial radiation therapy system, the most direct head-to-head competitor to Xstrahl's 100/150/200 series for non-melanoma skin cancer treatment in dermatology practices.

Emerging players

  • RaySearch Laboratories: RaySearch develops RayStation and RayCare treatment planning and oncology information systems that overlap with Xstrahl's XBeam and MuriSuite planning/control software offerings for radiation therapy and research workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Xstrahl social profiles

Digital presence

Xstrahl financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Xstrahl leadership team

Management profile

Number of profiles

Profiles11 records

Xstrahl funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Xstrahl M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xstrahl

What does Xstrahl do?

Xstrahl designs, manufactures, and sells X-ray radiation therapy and research systems. Its clinical product lines deliver superficial and orthovoltage radiotherapy plus electronic brachytherapy for treating non-melanoma skin cancer, keloid scarring, and benign conditions in dermatology and radiation oncology settings. Its research product lines deliver image-guided small animal irradiators and cabinet irradiators with FLASH ultra-high dose rate capability for translational preclinical radiation research at universities, pharmaceutical companies, and contract research organizations.

Is Xstrahl a public or private company?

Xstrahl is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Xstrahl founded?

Xstrahl was founded in 1999. It employs 51 to 100 people.

Where is Xstrahl based?

Xstrahl is headquartered in Duluth, United States, in the North America region.

How does Xstrahl make money?

Four revenue lines are on record. Medical Systems Hardware Sales are the primary driver. The others are professional Services and Training, technical Support and Maintenance and software Licenses.

Who are Xstrahl's main competitors?

Broad incumbents on record are Elekta, Varian Medical Systems (Siemens Healthineers), Accuray, Eckert & Ziegler and Revvity (PerkinElmer Life Sciences). Direct peers are IntraOp Medical, BEBIG Medical (Mick Radio-Nuclear Instruments), Mevion Medical Systems and Sensus Healthcare. RaySearch Laboratories is listed as an emerging player.

Does Xstrahl have an API?

No public API is recorded for Xstrahl.

What industry is Xstrahl in?

Xstrahl's product category is Radiation Therapy Equipment. Its primary akta.pro industry code is HLAHABAA, X-ray & Fluoroscopy Systems, with a secondary code of HLAKAFAC, Radiation Oncology. Its NAICS code is 334517 and its SIC code is 3844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NatureA preclinical radiotherapy dosimetry audit using a realistic 3D printed murine phantomA postal audit of 7 UK centres using Xstrahl SARRPs measured dose delivery with a 3D printed murine phantom containing alanine pellets and Gafchromic EBT3 film. For static fields, the absolute difference between planned and alanine-measured dose was 4.1 ± 4.3%, and for arc fields it was -1.2% ± 6.1%. The audit indicates further work on preclinical radiotherapy quality assurance is needed.PR NewswireRADiant to Exhibit at the 2019 American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago, ILXstrahl Medical is featuring its RADiant dual-modality radiotherapy treatment system at the 2019 American Society for Dermatologic Surgery Annual Meeting in Chicago from October 24-27, 2019 at booth #401. The RADiant system is designed specifically for dermatologists to treat non-melanoma skin cancer, offering both superficial radiotherapy and electronic brachytherapy options with treatments typically lasting 15 minutes. Xstrahl, a medical technology company with more than 20 years of experience, operates systems at over 700 treatment and research facilities worldwide.PR NewswireXstrahl Partners with C&C Irradiator Service to Supply Safe Irradiation Systems in the U.S.Xstrahl has partnered with C&C Irradiator Service to supply next-generation X-ray irradiator systems to replace cesium-137 sources across the United States. The agreement provides a full replacement solution, from decommissioning existing gamma irradiators to installing new X-ray systems, facilitating a smooth technology transition for facilities nationwide. The Department of Energy's National Nuclear Security Administration is supporting these conversions through the Cesium Irradiator Replacement Project, which offers financial incentives for facilities switching to non-radioisotopic alternatives.PR NewswireXstrahl Spotlights RADiant Dual Modality Treatment System at Texas Dermatology 2019Xstrahl Medical is featuring its RADiant dual modality treatment system at the Fall Texas Dermatology meeting in San Antonio, Texas from September 27-29, 2019. The system offers both superficial radiotherapy and electronic brachytherapy options designed specifically for dermatologists to treat non-melanoma skin cancer. Treatment is delivered in approximately 15 minutes without requiring lead shielding, allowing the technology to be easily incorporated into dermatology offices.PR NewswireXstrahl Spotlights New RADiant Treatment System at AOCD 2019Xstrahl Medical is spotlighting its RADiant dual modality radiotherapy treatment system at the Fall American Osteopathic College of Dermatology meeting in Nashville, Tennessee from September 26-28, 2019. The RADiant system offers superficial radiotherapy and electronic brachytherapy for non-melanoma skin cancer treatment, designed specifically for dermatologists with typically no lead shielding requirements. Xstrahl Group is a UK-headquartered designer and manufacturer of superficial orthovoltage medical X-ray systems with manufacturing facilities in both the UK and USA.PR NewswireXstrahl Spotlights New RADiant Treatment System at CalDerm 2019Xstrahl Medical is featuring its RADiant dual-modality radiotherapy treatment system at the California Society of Dermatology's annual symposium in Santa Barbara from September 20-22, 2019. The system, designed specifically for dermatologists, combines superficial radiotherapy and electronic brachytherapy for non-melanoma skin cancer treatment, offering a pain-free alternative when Moh's surgery is unavailable or patients are unsuitable for surgery. The company highlights that treatments typically take about 15 minutes and treatment rooms generally do not require lead shielding.PR NewswireXstrahl Supports Open Call for Animal Models in Radiotherapy ResearchXstrahl Life Sciences announced it is supporting an open call for original research articles and reviews on the development and application of animal models in radiotherapy research, to be published in the peer-reviewed journal Cancers. The special issue, with a December 15, 2019 submission deadline, aims to highlight advances in modeling radiotherapy response using animal models such as those studied on the Xstrahl Small Animal Radiation Research Platform. Xstrahl issued this press release to promote scientific advances made on its preclinical radiation research systems.PR NewswireXstrahl Introduces Image-Guidance for Superficial and Orthovoltage Radiotherapy SystemsXstrahl, a global leader in orthovoltage radiotherapy devices, has introduced the XSight image-guidance system at the ASTRO meeting in Chicago, addressing customer demand for enhanced visualization during radiotherapy treatment. The system provides real-time treatment alignment views and is initially available as an optional extra for Xstrahl's 150kV and 200kV treatment systems, with compatibility for retrofitting to many of the company's 700 global installed units. Headquartered in the UK with manufacturing facilities in both the UK and USA, Xstrahl serves hospitals and clinics worldwide treating skin cancer and dermatological conditions.PR NewswireXstrahl Spotlights Full Range of X-Ray Therapy and Radiation Research Systems at ASTRO 2019Xstrahl, a global leader in superficial radiotherapy devices for non-melanoma skin cancer and dermatological conditions, is showcasing its full product range at ASTRO 2019, including its RADiant treatment system and radiation research platforms. The company is introducing new image guidance capabilities for its treatment devices and the SARRP beamline system for advanced radiation research. CEO Adrian Treverton stated that image guidance enhances radiotherapy precision by giving clinicians real-time views of treatment alignment.PR NewswireXstrahl Launches the New SARRP Beamline for Proton, Photon, Carbon and Flash Pre-Clinical ExperimentsXstrahl Life Science, a global leader in pre-clinical X-ray systems, has launched its latest SARRP beamline system designed for proton, photon, carbon, and flash pre-clinical experiments. The new platform offers improved imaging capabilities for beamline research and can be extended with the Xstrahl MuriGlo, the industry\'s first 3D bioluminescent optical imaging modality. The company, with facilities in the UK, USA, and Germany, positions this launch as addressing the growing demand for advanced radiation research tools.